Sana Biotechnology SANA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's financing cash flow?
- Sana Biotechnology (SANA) reported financing cash flow of -$128K in Q1 2026.
- How has Sana Biotechnology's financing cash flow changed year-over-year?
- Sana Biotechnology's financing cash flow decreased by 113.0% year-over-year, from $982K to -$128K.
- What is the long-term trend for Sana Biotechnology's financing cash flow?
- Over 4 years (2021 to 2025), Sana Biotechnology's financing cash flow has grown at a -32.8% compound annual growth rate (CAGR), from $631.75M to $128.73M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.